Reuters logo
BRIEF-Hunan Er-kang Pharmaceutical sees 2016 Q1 to Q3 net profit outlook up 60 pct to 80 pct
September 30, 2016 / 10:26 AM / a year ago

BRIEF-Hunan Er-kang Pharmaceutical sees 2016 Q1 to Q3 net profit outlook up 60 pct to 80 pct

Sept 30 (Reuters) - Hunan Er-kang Pharmaceutical :

* Sees net profit for 2016 Q1 to Q3 up 60 percent to 80 percent, or to be 682.6 million yuan to 768 million yuan

* Says the net profit of 2015 Q1 to Q3 was 426.6 million yuan

Source text in Chinese: goo.gl/mR85p7

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below